Ask AI
ProCE Banner Activity

Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?

Slideset Download
Download this brief slideset for an update on biomarkers to guide treatment of patients with ES-SCLC with immunotherapy.

Released: February 01, 2021

Expiration: January 31, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Benjamin Levy, MD

Associate Professor of Oncology
Johns Hopkins
Baltimore, Maryland